4.7 Article

In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model

Related references

Note: Only part of the references are listed.
Review Microbiology

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

Li-Yang Hsu et al.

CLINICAL MICROBIOLOGY REVIEWS (2017)

Article Infectious Diseases

In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria

David M. Livermore et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Review Immunology

Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options

Chang-Ro Lee et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)

Review Biotechnology & Applied Microbiology

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

Sirijan Santajit et al.

BIOMED RESEARCH INTERNATIONAL (2016)

Article Infectious Diseases

OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'

Akihiro Morinaka et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

Review Infectious Diseases

Cefepime: a reappraisal in an era of increasing antimicrobial resistance

Andrea Endimiani et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)